tiprankstipranks
Trending News
More News >
Silence Therapeutics (SLN)
NASDAQ:SLN
US Market
Advertisement

Silence Therapeutics (SLN) Ownership - Who Owns Silence Therapeutics?

Compare
176 Followers

Silence Therapeutics (SLN) Ownership Overview

28.25%0.08%36.63%0.48%34.56%
28.25% Insiders
36.63% Other Institutional Investors
0.48% ETFs
34.56% Public Companies and
Individual Investors
The ownership structure of Silence Therapeutics (SLN) stock is a mix of institutional, retail, and individual investors. Approximately 37.19% of the company’s stock is owned by Institutional Investors, 28.25% is owned by Insiders, and 34.56% is owned by Public Companies and Individual Investors.
The ownership structure of Silence Therapeutics (SLN) stock is a mix of institutional, retail, and individual investors. Approximately 36.71% of the company’s stock is owned by Institutional Investors, 28.25% is owned by Insiders, and 0.48% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 28, 2025
xxxxxxxxxxxxx
$520155
Apr 24, 2025
xxxxxxxxxxxxx
$314000
Apr 22, 2025
xxxxxxxxxxxxx
$469005
Apr 15, 2025
xxxxxxxxxxxxx
$505140

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$379267

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,461,299Insider22.15%65,069,280
8,495,310Insider6.10%52,840,828
387,400Institution0.82%2,409,628
194,746Institution0.41%1,211,320
134,492Institution0.28%836,540
29,417Institution0.06%182,974
19,941Institution0.04%124,033
7,708Institution0.02%47,944
5,800Institution0.01%36,076
4,238Institution<0.01%26,360

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
29,417Institution0.06%182,974
5,800Institution0.01%36,076
4,238Institution<0.01%26,360

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
144,374Institution0.31%898,006
25,186Institution0.05%159,931
19,941Institution0.04%124,033
7,708Institution0.02%48,946
1,661Institution<0.01%10,331

FAQ

Who Owns Silence Therapeutics (SLN)?
According to the latest TipRanks data, approximately 36.63% of the company's stock is held by institutional investors, 28.25% is held by insiders, and 34.56% is held by retail investors.
    What percentage of Silence Therapeutics (SLN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 36.63% of Silence Therapeutics (SLN) stock is held by institutional investors.
      What percentage of Silence Therapeutics (SLN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 34.56% of Silence Therapeutics (SLN) stock is held by retail investors.
        Who owns the most shares of Silence Therapeutics (SLN)?
        Richard Ian Griffiths owns the most shares of Silence Therapeutics (SLN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis